Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
KLF5 protects the intestinal epithelium against Th17 immune response in a murine colitis model
Jason Shieh, Timothy H. Chu, Yang Liu, Julie Kim, Ainara Ruiz de Sabando, Soma Kobayashi, Sui Y. Zee, Brian S. Sheridan, Agnieszka B. Bialkowska, Vincent W. Yang
Jason Shieh, Timothy H. Chu, Yang Liu, Julie Kim, Ainara Ruiz de Sabando, Soma Kobayashi, Sui Y. Zee, Brian S. Sheridan, Agnieszka B. Bialkowska, Vincent W. Yang
View: Text | PDF
Research Article Gastroenterology Inflammation

KLF5 protects the intestinal epithelium against Th17 immune response in a murine colitis model

  • Text
  • PDF
Abstract

Inflammatory bowel disease (IBD) is a chronic illness characterized by dysregulated immune cascades in the intestines, in which the Th17 immune response plays an important role. We demonstrated that mice with intestinal epithelium–specific deletion of Krüppel-like factor 5 (Klf5) developed Th17-dependent colonic inflammation. In the absence of KLF5, there was aberrant cellular localization of phosphorylated STAT3, an essential mediator of the Th17-associated cytokine, IL-22, which is required for epithelial tissue regeneration. In contrast, mitigation of IL-17A with anti–IL-17A neutralizing antibody attenuated colitis in Klf5-deficient mice. There was also a considerable shift in the colonic microbiota of Klf5-deficient mice that phenocopied human IBD. Notably, the inflammatory response due to Klf5 deletion was alleviated by antibiotic treatment, implicating the role of microbiota in pathogenesis. Finally, human colitic tissues had reduced KLF5 levels when compared with healthy tissues. Together, these findings demonstrated the importance of KLF5 in protecting the intestinal epithelium against Th17-mediated immune and inflammatory responses. The mice described herein may serve as a potential model for human IBD.

Authors

Jason Shieh, Timothy H. Chu, Yang Liu, Julie Kim, Ainara Ruiz de Sabando, Soma Kobayashi, Sui Y. Zee, Brian S. Sheridan, Agnieszka B. Bialkowska, Vincent W. Yang

×

Figure 4

Intestine-specific deletion of Klf5 results in increased Th17 cells and concentrations of IL-17 and IL-22.

Options: View larger image (or click on image) Download as PowerPoint
Intestine-specific deletion of Klf5 results in increased Th17 cells and ...
(A) Graph representation of gated populations. Graph on the left represents the percentage of CD45+ populations from the total number of live cells (n = 4). Middle graph represents the percentage of CD3+ cells out of the total CD45+ cells (n = 4). The right graph represents percentage of CD11c+ and CD103+ double-positive populations for conventional DC type 2 (cDC2) (n = 4). (B) Percentage of total CD4+ T cells that express the hallmark transcription factor for Th17, RORγT (n = 5). (C) Quantification of leukocytes treated with brefeldin A and ionomycin for cytokine stimulation. Percentages of cells with IFN-γ, IL-17A, and IL-22 were calculated from the total CD4+ T cell population (n = 16). (D) Quantification of IL-17A by ELISA from total tissue lysate (n = 4). (E) Immunofluorescence (IF) staining of IL-17A in whole colon tissue from CO- and TAM-treated Klf5ΔIND mice. (F) Quantification of cell numbers in proximal and distal colonic regions from the IF images (n = 3). (G) Quantification of IL-22 ELISA from total tissue lysate (n = 4). (H) IF staining of IL-22 in whole colon tissue from CO- and TAM-treated Klf5ΔIND mice. (I) Quantification of cell numbers in proximal and distal colonic regions from the IF images (n = 3). Data from graphs represent mean ± SEM, *P < 0.05; **P < 0.01; ***P < 0.001; 1-way ANOVA. Scale bars: 70 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts